Efficacy and safety of neoadjuvant combination immunotherapy in surgically resectable malignant solid tumors: a systematic review and meta-analysis

CONCLUSION: This study demonstrated the efficacy of neoadjuvant combination immunotherapy. Given that the majority of the included trials were phase II with small sample sizes, further multicenter phase III randomized controlled trials should be conducted to validate the findings of the review.PMID:38436076 | DOI:10.1080/14737140.2024.2325404
Source: Expert Review of Anticancer Therapy - Category: Cancer & Oncology Authors: Source Type: research